Sema4 is the developer of an AI-driven patient-centered genomic and clinical data insight platform designed to to transform healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology.

Register for Details

For more details on financing and valuation for Sema4, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Sema4

Forge green plus iconForge green minus icon

What is Sema4's IPO price?

Sema4's IPO price is $0.3106 as of 1/9/23.
Forge green plus iconForge green minus icon

What is Sema4's funding to date?

Sema4 has raised $368.26MM to date.
Forge green plus iconForge green minus icon

When was Sema4 founded?

Sema4 was founded in 2015.

Sema4 Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
7/29/2020 Series C $121.4MM raised $XXX.XX $XXX.XX
8/22/2019 Series B $127.61MM raised $XXX.XX $XXX.XX
3/21/2018 Series A-1 and A-2 $119.25MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Nov 15, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.